Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lysine acetyltransferase 5 (KAT5), commonly known as TIP60, is a member of the MYST family of histone acetyltransferases that modifies chromatin structure by acetylating histone and non-histone proteins. KAT5 is crucial for regulating gene expression, DNA repair, apoptosis, cell cycle progression, and development. It performs its functions by catalyzing acetylation of specific lysine residues, thereby influencing the interactions between DNA and proteins involved in transcription and repair. KAT5 can interact with viral proteins, such as HIV-1 Tat, and is involved in regulating critical tumor suppressor pathways including p53. Altered KAT5 activity is implicated in various cancers, HIV infection, neurodegenerative disorders, and developmental abnormalities. Although no approved drugs directly target KAT5, it remains a key subject in epigenetic therapeutic research.
Inhibition of acetyltransferase activity; Modulation of chromatin remodeling; Regulation of DNA repair pathways; Induction of apoptosis via p53 acetylation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lysine acetyltransferase 5 (KAT5).